EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Association of Remnant Cholesterol Inflammatory Index with Stroke, Heart Disease and All-Cause Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: A National Cohort Study

Huan Chen, Jing-Yun Wu, Hao Yan, Jian Gao, Chuan Li, Jia-Hao Xie, Xiao-Lin Wang, Ji-Long Huang, Dan Liu, Zhi-Hao Li, Chen Mao

Nutrients · 08.01.2026 · 18 (2) · 205

DOI: 10.3390/nu18020205 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Nutrients, online erschienen am 08.01.2026. Verfasst von Huan Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Stroke, Cholesterol, Metabolic Syndrome, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Remnant Cholesterol Inflammatory index (RCII) has been proposed as a marker of insulin resistance and systemic inflammation. However, its associations with incident stroke, incident heart disease, and all-cause mortality among individuals with cardiovascular–kidney–metabolic (CKM) syndrome stages 0–3 remain uncertain.

Methods

This longitudinal cohort study used data from the China Health and Retirement Longitudinal Study (CHARLS). The remnant cholesterol inflammatory index (RCII) was calculated as [RC (mg/dL) × hs-CRP (mg/L)]/10. Outcomes included incident stroke, incident heart disease, and all-cause mortality. Covariates were prespecified based on established risk factors. Cox proportional hazards models and restricted cubic spline (RCS) analyses were used to evaluate associations between RCII and each outcome. Long-term RCII patterns were identified using k-means clustering. Robustness was assessed using subgroup and sensitivity analyses.

Results

The final study involved 6994 participants in the stroke and heart disease cohort and 7245 participants in the all-cause mortality cohort, all within CKM syndrome stages 0–3. Higher baseline RCII was associated with increased risks of stroke (HR = 1.55, 95% CI: 1.14–2.12) and all-cause mortality (HR = 1.67, 95% CI: 1.37–2.04) compared with the lowest quantile. Cumulative RCII showed a stronger association with all-cause mortality (HR for Q3 = 2.18, 95% CI: 1.54–3.11). RCS analysis suggested a J-shaped, non-linear association between cumulative RCII and all-cause mortality. (p for non-linearity < 0.05). K-means clustering further indicated that, relative to the reference group, cluster 2 (high-to-higher) had the highest risk of incident heart disease, whereas cluster 3 (high-to-moderate) had the highest risk of all-cause mortality.

Conclusions

Higher RCII levels were associated with higher risks of stroke, heart disease, and all-cause mortality among individuals with CKM stages 0–3. RCII may serve as a promising biomarker for early risk stratification in clinic and prevention efforts in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeCholesterolMetabolic SyndromeInflammationHeart DiseasesCardio-Renal SyndromeHumansFemaleLongitudinal StudiesMaleChinaAgedMiddle AgedBiomarkersRisk FactorsProportional Hazards ModelsCohort StudiesC-Reactive Protein

Stichwörter der Autor:innen

CHARLSall-cause mortalityremnant cholesterol inflammatory indexstroke

Substanzen

CholesterolBiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou 510515, China.
  • National Institute of Health Data Science, Southern Medical University, Guangzhou 510515, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Wu, J. Y., Yan, H., Gao, J., Li, C., Xie, J. H., Wang, X. L., Huang, J. L., Liu, D., Li, Z. H., & Mao, C. (2026). Association of Remnant Cholesterol Inflammatory Index with Stroke, Heart Disease and All-Cause Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: A National Cohort Study. Nutrients, 18(2), 205. https://doi.org/10.3390/nu18020205

Vancouver

Chen H, Wu JY, Yan H, Gao J, Li C, Xie JH, et al. Association of Remnant Cholesterol Inflammatory Index with Stroke, Heart Disease and All-Cause Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: A National Cohort Study. Nutrients. 2026;18(2):205. doi:10.3390/nu18020205

BibTeX
@article{Chen2026,
  author = {Chen, Huan and Wu, Jing-Yun and Yan, Hao and Gao, Jian and Li, Chuan and Xie, Jia-Hao and Wang, Xiao-Lin and Huang, Ji-Long and Liu, Dan and Li, Zhi-Hao and Mao, Chen},
  title = {Association of Remnant Cholesterol Inflammatory Index with Stroke, Heart Disease and All-Cause Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: A National Cohort Study},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {205},
  doi = {10.3390/nu18020205}
}
Kostenlos starten →